MANGOCEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2191 USD | -12.36% |
|
-21.72% | -20.87% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 0.01 0.75 | Sales 2023 | 0.73 61.05 | Capitalization | 5.83M 486M |
|---|---|---|---|---|---|
| Net income 2022 | -2M -167M | Net income 2023 | -9M -751M | EV / Sales 2022 * | - |
| Net cash position 2022 | 330K 27.54M | Net cash position 2023 | 610K 50.94M | EV / Sales 2023 | 71,29,952 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.48
x | Employees | 3 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.61% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -12.36% | ||
| 1 week | -21.72% | ||
| Current month | -9.87% | ||
| 1 month | -9.57% | ||
| 3 months | -10.90% | ||
| 6 months | -49.27% | ||
| Current year | -20.87% |
1 week
0.21
0.27
1 month
0.210.31
Current year
0.140.49
1 year
0.142.38
3 years
0.144.37
5 years
0.144.37
10 years
0.144.37
| Managers | Title | Age | Since |
|---|---|---|---|
Jacob Cohen
CEO | Chief Executive Officer | 45 | 01/21/01 |
Eugene Johnston
DFI | Director of Finance/CFO | 60 | 01/22/01 |
Amanda Hammer
COO | Chief Operating Officer | 38 | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Alex Hamilton
BRD | Director/Board Member | 49 | 14/22/14 |
Jacob Cohen
CEO | Chief Executive Officer | 45 | 01/21/01 |
| Director/Board Member | 44 | 14/22/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 0.2191 | -12.36% | 110,885 |
| 13/24/13 | 0.25 | -3.21% | 106,848 |
| 10/24/10 | 0.2583 | -4.33% | 62,047 |
| 09/24/09 | 0.27 | +4.77% | 123,123 |
| 08/24/08 | 0.2577 | -7.93% | 41,219 |
Delayed Quote Nasdaq, May 15, 2024 at 02:00 am IST
More quotes
Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of menâs health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Calendar
17/06/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -20.87% | 5.99M | |
| +54.38% | 2.77B | |
| +115.18% | 703M | |
| +12.20% | 484M | |
| -66.59% | 145M | |
| -46.04% | 66.82M |
- Stock Market
- Equities
- MGRX Stock
